Kodiak Sciences focuses on developing novel therapeutics for the treatment of ophthalmic diseases.
Business Model:
Revenue: $0
Employees: 51-200
Address: 1200 Page Mill Road
City: Palo Alto
State: CA
Zip: 94304
Country: US
Kodiak Sciences focuses on developing novel therapeutics for the treatment of ophthalmic diseases.
Contact Phone:
+16502810850
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/3/2018
IPO Valuation:
$365M
Ticker Symbol:
KOD
IPO Price:
$10/share
Amount Raised:
$90M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2009 | Equity | $1.8M | 4/2018 | Convertible Note | 3 | $33M |
Perceptive Advisors Rivas Capital ArrowMark Partners ArrowMark Partners Perceptive Advisors Perceptive Advisors Rivas Capital ArrowMark Partners ArrowMark Partners Perceptive Advisors |
10/2018 | IPO | $90M | 9/2015 | Series B | $34M | 1/2016 | Series B | $34M | 7/2009 | Venture Round | $1.8M | 12/2019 | Post-IPO Equity | $317.4M | 11/2020 | Post-IPO Equity | $645M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|